Northrop Grumman Corporation filings document formal disclosures for an NYSE-listed aerospace and defense contractor with common stock trading under NOC. Recent 8-K reports furnish quarterly and annual earnings releases, summarize operating results and awards, and record material events such as director elections, officer transitions, compensation actions and credit-facility agreements.
The company's proxy materials describe board structure, committee assignments, executive compensation and annual meeting governance. Its financing disclosures cover senior unsecured revolving credit arrangements, commercial paper support, covenants, events of default and capital-structure terms relevant to the company's defense and space systems operations.
Capital International Investors reports 7,321,667 shares (5.2%) of Northrop Grumman common stock. Amendment No. 9 to a Schedule 13G/A states CII is deemed beneficial owner of 7,321,667 shares of Common Stock (CUSIP 666807102) of Northrop Grumman Corp. as of 03/31/2026. The filing lists 7,124,472 shares subject to sole voting power and 7,321,667 shares subject to sole dispositive power, based on 141,921,621 shares believed outstanding.
Northrop Grumman director Mark A. Welsh III sold 95 shares of common stock in pre-planned transactions. On May 4, 2026, he executed 11 open-market sales at prices between $566.60 and $577.05 per share under a Rule 10b5-1 trading plan adopted on August 23, 2025. After these sales, he directly owned 4,121 Northrop Grumman shares.
Northrop Grumman Corp ownership filing shows Vanguard Capital Management beneficially owned 10,248,540 shares of Common Stock, representing 7.22% of the class as of 03/31/2026. The filing reports sole dispositive power over 10,248,540 shares and sole voting power for 1,299,313 shares. The disclosure attributes holdings to Vanguard Capital Management and specified Vanguard affiliates and notes these include securities held by Vanguard funds and managed accounts.
Northrop Grumman Corporation registered a shelf on Form S-3 to offer senior debt securities and common stock. The prospectus dated April 21, 2026 describes a shelf registration permitting sales from time to time, with specific terms and amounts to be provided in prospectus supplements.
The prospectus states proceeds will be used for general corporate purposes, including repayment of debt, share repurchases, working capital, capital expenditures and acquisitions. The filing incorporates by reference the company’s recent SEC reports and identifies The Bank of New York Mellon as indenture trustee for senior debt.
Northrop Grumman’s first quarter 2026 results show sharply higher profitability on modest sales growth. Sales rose 4% to $9.9 billion, while operating income jumped to $989 million from $573 million as operating margin expanded to 10.0% from 6.1%.
Net earnings increased 82% to $875 million and diluted EPS climbed to $6.14 from $3.32, helped by the absence of the large B‑21 loss charge recorded a year earlier and stronger segment performance, particularly in Aeronautics and Mission Systems.
Backlog remained very strong at $95.6 billion, with about 60% expected to turn into revenue within 24 months. Free cash flow was negative $1.8 billion, reflecting typical first‑half working capital usage and continued investment, including capacity expansion on the B‑21 program.
Northrop Grumman reported strong first quarter 2026 results, with sales up 4% to $9.9 billion and diluted EPS up 85% to $6.14. Net earnings rose 82% to $875 million, driven mainly by much higher operating income and pension benefits versus last year’s B‑21 loss provision.
Segment operating income nearly doubled, lifting the segment margin from 6.0% to 10.8%, led by Aeronautics Systems and Mission Systems. Space Systems saw lower sales and margins due to the NGI wind‑down and a $71 million GEM 63XL charge. Free cash flow was a use of $1.8 billion, similar to last year, reflecting typical first‑half working capital timing. The company ended the quarter with $95.6 billion of backlog and reaffirmed its 2026 guidance for sales, segment operating income, MTM‑adjusted EPS and free cash flow.
Northrop Grumman Corporation is asking shareholders to vote at its 2026 virtual annual meeting on 11 director nominees, executive pay, auditor ratification, and a shareholder proposal for an independent board chair, which the Board recommends voting against.
For 2025, sales rose 2% to $42 billion, with organic sales up 3% and operating margin reaching 10.8%. Diluted EPS was $29.08, with mark-to-market adjusted EPS of $26.34, exceeding guidance. The company ended 2025 with record backlog of $95.7 billion and generated $4.8 billion in operating cash flow and $3.3 billion in free cash flow, while increasing its quarterly dividend by 12%.
The proxy emphasizes strong board independence (about 92% independent directors), a lead independent director with extensive responsibilities, proxy access rights, and majority voting for directors. Executive compensation is heavily performance-based, with over 80% variable pay and non-financial metrics tied to customers, people, and environmental sustainability.
Northrop Grumman director Marianne Catherine Brown reported acquiring 68 shares of common stock valued at $682.24 per share on a deferred basis. The shares were credited to a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. Following this award, she holds 11,066 shares of common stock, including dividends, in the stock unit account pursuant to the plan. This reflects routine equity-based compensation rather than an open‑market stock purchase.